Molly Lamb
Concepts (360)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Muscular Dystrophy, Duchenne | 6 | 2022 | 80 | 1.710 |
Why?
| Diet | 10 | 2019 | 1080 | 1.390 |
Why?
| Zika Virus Infection | 5 | 2022 | 85 | 1.280 |
Why?
| Autoimmunity | 8 | 2020 | 814 | 1.250 |
Why?
| Islets of Langerhans | 6 | 2014 | 728 | 1.110 |
Why?
| Zika Virus | 3 | 2022 | 61 | 1.030 |
Why?
| Diabetes Mellitus, Type 1 | 12 | 2020 | 3248 | 0.980 |
Why?
| Child Development | 4 | 2022 | 387 | 0.970 |
Why?
| Guatemala | 20 | 2023 | 266 | 0.960 |
Why?
| Rural Population | 12 | 2022 | 446 | 0.880 |
Why?
| Body Weight | 2 | 2018 | 869 | 0.850 |
Why?
| Growth Disorders | 2 | 2023 | 77 | 0.840 |
Why?
| Dengue Virus | 1 | 2022 | 31 | 0.820 |
Why?
| Body Height | 2 | 2016 | 180 | 0.800 |
Why?
| Child | 46 | 2023 | 18352 | 0.800 |
Why?
| Child, Preschool | 36 | 2023 | 9079 | 0.790 |
Why?
| Dengue | 1 | 2022 | 59 | 0.790 |
Why?
| Influenza, Human | 6 | 2022 | 546 | 0.790 |
Why?
| Infant | 34 | 2023 | 7935 | 0.770 |
Why?
| Head | 1 | 2022 | 85 | 0.750 |
Why?
| Child Nutritional Physiological Phenomena | 3 | 2015 | 97 | 0.560 |
Why?
| Microcephaly | 3 | 2023 | 51 | 0.540 |
Why?
| Dietary Carbohydrates | 2 | 2015 | 139 | 0.530 |
Why?
| Pregnenediones | 1 | 2016 | 21 | 0.530 |
Why?
| Humans | 79 | 2023 | 114757 | 0.500 |
Why?
| HLA-DR Antigens | 2 | 2014 | 220 | 0.500 |
Why?
| Milk | 2 | 2014 | 124 | 0.490 |
Why?
| Carbohydrates | 1 | 2015 | 55 | 0.490 |
Why?
| Prednisone | 1 | 2016 | 231 | 0.490 |
Why?
| Infant, Newborn | 15 | 2022 | 5035 | 0.490 |
Why?
| Adrenal Cortex Hormones | 1 | 2018 | 498 | 0.490 |
Why?
| Carbonic Anhydrases | 2 | 2005 | 13 | 0.490 |
Why?
| Culicidae | 2 | 2005 | 29 | 0.480 |
Why?
| Body Mass Index | 8 | 2020 | 1958 | 0.460 |
Why?
| Prospective Studies | 16 | 2023 | 6217 | 0.440 |
Why?
| Disease Progression | 4 | 2015 | 2387 | 0.440 |
Why?
| Viruses | 3 | 2023 | 94 | 0.430 |
Why?
| Infant Food | 2 | 2015 | 63 | 0.410 |
Why?
| Sarcoma, Kaposi | 2 | 2023 | 68 | 0.400 |
Why?
| Immunoglobulin G | 3 | 2022 | 774 | 0.390 |
Why?
| Seroepidemiologic Studies | 5 | 2023 | 138 | 0.390 |
Why?
| Glucocorticoids | 1 | 2016 | 532 | 0.390 |
Why?
| Eating | 1 | 2014 | 345 | 0.380 |
Why?
| Audiovisual Aids | 1 | 2010 | 16 | 0.370 |
Why?
| Male | 39 | 2022 | 55579 | 0.360 |
Why?
| Sexual Maturation | 1 | 2010 | 47 | 0.360 |
Why?
| Hypercholesterolemia | 1 | 2011 | 90 | 0.360 |
Why?
| Hyperlipidemias | 1 | 2011 | 122 | 0.360 |
Why?
| Antibodies, Viral | 6 | 2023 | 521 | 0.350 |
Why?
| Overweight | 3 | 2019 | 471 | 0.350 |
Why?
| Pregnancy | 11 | 2023 | 5525 | 0.350 |
Why?
| Female | 44 | 2023 | 59507 | 0.350 |
Why?
| Virus Diseases | 2 | 2022 | 195 | 0.340 |
Why?
| Caregivers | 3 | 2021 | 717 | 0.330 |
Why?
| Obesity | 5 | 2015 | 2513 | 0.320 |
Why?
| Self Concept | 1 | 2010 | 213 | 0.320 |
Why?
| Carbonic Anhydrase Inhibitors | 2 | 2005 | 17 | 0.310 |
Why?
| Meningitis, Bacterial | 2 | 2022 | 48 | 0.310 |
Why?
| Glycemic Index | 1 | 2008 | 21 | 0.310 |
Why?
| Delivery, Obstetric | 2 | 2019 | 119 | 0.310 |
Why?
| Autoantibodies | 5 | 2020 | 1350 | 0.310 |
Why?
| Interviews as Topic | 1 | 2010 | 582 | 0.310 |
Why?
| Lipids | 2 | 2011 | 582 | 0.310 |
Why?
| Respiratory Tract Infections | 2 | 2022 | 319 | 0.300 |
Why?
| Caliciviridae Infections | 2 | 2018 | 17 | 0.290 |
Why?
| Adolescent | 18 | 2022 | 17808 | 0.290 |
Why?
| Adipose Tissue | 1 | 2011 | 539 | 0.290 |
Why?
| Norovirus | 2 | 2018 | 23 | 0.290 |
Why?
| Body Composition | 1 | 2011 | 592 | 0.290 |
Why?
| Viral Vaccines | 2 | 2018 | 88 | 0.290 |
Why?
| Mental Health Services | 2 | 2021 | 316 | 0.290 |
Why?
| Psychology, Child | 1 | 2007 | 38 | 0.280 |
Why?
| Genotype | 4 | 2015 | 1774 | 0.280 |
Why?
| Gastroenteritis | 2 | 2017 | 65 | 0.270 |
Why?
| Herpesvirus 8, Human | 2 | 2023 | 61 | 0.270 |
Why?
| Cross-Sectional Studies | 7 | 2023 | 4409 | 0.260 |
Why?
| Surveys and Questionnaires | 7 | 2022 | 4625 | 0.260 |
Why?
| Cohort Studies | 8 | 2022 | 4901 | 0.260 |
Why?
| Gastrointestinal Tract | 2 | 2019 | 169 | 0.250 |
Why?
| Schools | 4 | 2023 | 399 | 0.250 |
Why?
| Masks | 2 | 2022 | 46 | 0.250 |
Why?
| Risk Factors | 12 | 2021 | 8627 | 0.250 |
Why?
| Digestive System | 1 | 2004 | 27 | 0.230 |
Why?
| Coinfection | 2 | 2022 | 120 | 0.230 |
Why?
| Culex | 1 | 2023 | 13 | 0.220 |
Why?
| Young Adult | 13 | 2022 | 10463 | 0.220 |
Why?
| Educational Personnel | 1 | 2023 | 13 | 0.220 |
Why?
| Aedes | 1 | 2023 | 55 | 0.210 |
Why?
| HIV Seropositivity | 1 | 2023 | 109 | 0.210 |
Why?
| Prevalence | 8 | 2021 | 2249 | 0.210 |
Why?
| Metapneumovirus | 1 | 2022 | 12 | 0.210 |
Why?
| Cross Reactions | 1 | 2022 | 117 | 0.210 |
Why?
| Parents | 3 | 2023 | 1190 | 0.200 |
Why?
| Diarrhea | 2 | 2023 | 173 | 0.200 |
Why?
| Health Knowledge, Attitudes, Practice | 3 | 2023 | 1183 | 0.200 |
Why?
| Cephalometry | 1 | 2022 | 28 | 0.200 |
Why?
| Anthropometry | 1 | 2022 | 183 | 0.200 |
Why?
| Respiratory Syncytial Virus, Human | 1 | 2022 | 61 | 0.190 |
Why?
| Erythrocyte Membrane | 2 | 2015 | 50 | 0.190 |
Why?
| Oryza | 1 | 2021 | 20 | 0.190 |
Why?
| Proportional Hazards Models | 3 | 2015 | 1080 | 0.190 |
Why?
| Arsenic | 1 | 2021 | 37 | 0.190 |
Why?
| Cesarean Section | 2 | 2019 | 169 | 0.190 |
Why?
| Sexually Transmitted Diseases, Viral | 1 | 2021 | 7 | 0.190 |
Why?
| Respiratory Syncytial Virus Infections | 1 | 2022 | 98 | 0.190 |
Why?
| Family Health | 2 | 2015 | 194 | 0.190 |
Why?
| Midwifery | 1 | 2022 | 45 | 0.190 |
Why?
| Lead Poisoning | 1 | 2021 | 17 | 0.190 |
Why?
| Health Literacy | 1 | 2023 | 164 | 0.190 |
Why?
| Meningitis | 1 | 2022 | 74 | 0.180 |
Why?
| Malaria | 1 | 2021 | 49 | 0.180 |
Why?
| Lysine | 1 | 2022 | 242 | 0.180 |
Why?
| Emergency Responders | 1 | 2021 | 33 | 0.180 |
Why?
| Adult | 16 | 2022 | 30548 | 0.180 |
Why?
| Maternal Health Services | 1 | 2022 | 79 | 0.180 |
Why?
| Specimen Handling | 1 | 2022 | 156 | 0.180 |
Why?
| Fatty Acids, Omega-3 | 2 | 2015 | 122 | 0.180 |
Why?
| Birth Intervals | 1 | 2020 | 16 | 0.180 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2022 | 797 | 0.180 |
Why?
| Molecular Diagnostic Techniques | 1 | 2021 | 92 | 0.180 |
Why?
| Follow-Up Studies | 5 | 2021 | 4420 | 0.180 |
Why?
| Endpoint Determination | 1 | 2020 | 69 | 0.180 |
Why?
| Refugees | 1 | 2021 | 54 | 0.170 |
Why?
| Age of Onset | 4 | 2022 | 448 | 0.170 |
Why?
| Cesarean Section, Repeat | 1 | 2019 | 9 | 0.170 |
Why?
| Breast Feeding | 4 | 2015 | 370 | 0.170 |
Why?
| Intensive Care Units, Pediatric | 1 | 2021 | 147 | 0.170 |
Why?
| Regression Analysis | 1 | 2022 | 946 | 0.170 |
Why?
| Vaginal Birth after Cesarean | 1 | 2019 | 21 | 0.170 |
Why?
| Language Tests | 1 | 2019 | 31 | 0.170 |
Why?
| Sexual Partners | 1 | 2021 | 161 | 0.170 |
Why?
| Developing Countries | 1 | 2021 | 236 | 0.160 |
Why?
| Language Development Disorders | 1 | 2019 | 38 | 0.160 |
Why?
| Motor Skills | 1 | 2020 | 81 | 0.160 |
Why?
| Emergency Service, Hospital | 4 | 2022 | 1812 | 0.160 |
Why?
| Social Class | 2 | 2010 | 204 | 0.160 |
Why?
| Dietary Proteins | 2 | 2013 | 123 | 0.160 |
Why?
| Multiplex Polymerase Chain Reaction | 1 | 2019 | 45 | 0.160 |
Why?
| Pregnancy Complications, Infectious | 1 | 2022 | 288 | 0.160 |
Why?
| Epilepsy | 1 | 2022 | 277 | 0.160 |
Why?
| Adolescent Health | 1 | 2019 | 37 | 0.160 |
Why?
| Arbovirus Infections | 1 | 2018 | 17 | 0.160 |
Why?
| Sexual Behavior | 2 | 2021 | 440 | 0.160 |
Why?
| Muscular Dystrophies | 1 | 2018 | 36 | 0.160 |
Why?
| Public Health Surveillance | 1 | 2018 | 61 | 0.150 |
Why?
| HLA-DR4 Antigen | 2 | 2015 | 76 | 0.150 |
Why?
| HLA-DQ beta-Chains | 2 | 2015 | 58 | 0.150 |
Why?
| Linear Models | 3 | 2023 | 770 | 0.150 |
Why?
| HLA-DR3 Antigen | 2 | 2015 | 79 | 0.150 |
Why?
| Vaccines | 1 | 2023 | 375 | 0.150 |
Why?
| Pregnant Women | 1 | 2019 | 131 | 0.150 |
Why?
| Vaccination | 2 | 2023 | 1205 | 0.150 |
Why?
| Medicaid | 1 | 2021 | 407 | 0.150 |
Why?
| Sex Factors | 4 | 2010 | 1717 | 0.150 |
Why?
| Sentinel Surveillance | 1 | 2017 | 38 | 0.150 |
Why?
| Celiac Disease | 1 | 2020 | 264 | 0.140 |
Why?
| Family Characteristics | 4 | 2021 | 152 | 0.140 |
Why?
| Reproducibility of Results | 5 | 2021 | 2763 | 0.140 |
Why?
| Urban Population | 1 | 2019 | 398 | 0.140 |
Why?
| Cell Phone | 1 | 2017 | 76 | 0.140 |
Why?
| Down Syndrome | 1 | 2021 | 338 | 0.140 |
Why?
| Influenza Vaccines | 1 | 2021 | 498 | 0.130 |
Why?
| Neonatal Screening | 1 | 2017 | 152 | 0.130 |
Why?
| Micronutrients | 2 | 2007 | 78 | 0.130 |
Why?
| Fever | 1 | 2017 | 279 | 0.130 |
Why?
| Learning | 1 | 2020 | 352 | 0.130 |
Why?
| Health Resources | 1 | 2017 | 122 | 0.130 |
Why?
| Feeding Methods | 1 | 2015 | 6 | 0.130 |
Why?
| Mobile Applications | 1 | 2017 | 140 | 0.130 |
Why?
| F2-Isoprostanes | 1 | 2015 | 14 | 0.130 |
Why?
| Models, Psychological | 1 | 2017 | 296 | 0.120 |
Why?
| Methazolamide | 2 | 2005 | 3 | 0.120 |
Why?
| Energy Intake | 2 | 2008 | 427 | 0.120 |
Why?
| Oxygen Isotopes | 2 | 2005 | 19 | 0.120 |
Why?
| Acetazolamide | 2 | 2005 | 30 | 0.120 |
Why?
| United States | 9 | 2021 | 12176 | 0.120 |
Why?
| Histocytochemistry | 2 | 2005 | 79 | 0.120 |
Why?
| Nutrition Policy | 1 | 2015 | 54 | 0.120 |
Why?
| Walking | 1 | 2018 | 422 | 0.120 |
Why?
| District of Columbia | 2 | 2012 | 24 | 0.120 |
Why?
| Population Surveillance | 1 | 2017 | 392 | 0.120 |
Why?
| Food Supply | 1 | 2015 | 64 | 0.120 |
Why?
| Sensitivity and Specificity | 4 | 2022 | 1691 | 0.120 |
Why?
| Age Factors | 5 | 2015 | 2890 | 0.120 |
Why?
| Adolescent Behavior | 1 | 2019 | 489 | 0.110 |
Why?
| Species Specificity | 2 | 2005 | 545 | 0.110 |
Why?
| Hydrogen-Ion Concentration | 2 | 2005 | 511 | 0.110 |
Why?
| Case-Control Studies | 2 | 2021 | 3005 | 0.110 |
Why?
| Social Support | 1 | 2017 | 528 | 0.110 |
Why?
| Health Behavior | 1 | 2019 | 704 | 0.110 |
Why?
| Insulin | 2 | 2015 | 2079 | 0.110 |
Why?
| Patient Acceptance of Health Care | 1 | 2018 | 680 | 0.100 |
Why?
| Quality Improvement | 4 | 2022 | 951 | 0.100 |
Why?
| Psychometrics | 3 | 2021 | 607 | 0.100 |
Why?
| Seroconversion | 2 | 2023 | 45 | 0.100 |
Why?
| Kenya | 2 | 2023 | 97 | 0.100 |
Why?
| Contact Tracing | 1 | 2012 | 16 | 0.100 |
Why?
| Disease Susceptibility | 1 | 2014 | 316 | 0.100 |
Why?
| Transportation | 1 | 2012 | 44 | 0.100 |
Why?
| Dose-Response Relationship, Drug | 1 | 2016 | 1846 | 0.100 |
Why?
| Personal Protective Equipment | 2 | 2022 | 50 | 0.100 |
Why?
| Mass Spectrometry | 2 | 2005 | 633 | 0.100 |
Why?
| School Teachers | 2 | 2021 | 18 | 0.100 |
Why?
| Acute Disease | 3 | 2019 | 912 | 0.090 |
Why?
| Cattle | 1 | 2014 | 921 | 0.090 |
Why?
| Area Under Curve | 2 | 2009 | 275 | 0.090 |
Why?
| HLA Antigens | 2 | 2013 | 224 | 0.090 |
Why?
| Animals | 6 | 2023 | 31762 | 0.090 |
Why?
| Patient Compliance | 1 | 2015 | 525 | 0.090 |
Why?
| Tuberculosis, Pulmonary | 1 | 2012 | 112 | 0.090 |
Why?
| Quality of Life | 2 | 2022 | 2358 | 0.090 |
Why?
| Nutrition Surveys | 4 | 2015 | 224 | 0.090 |
Why?
| ROC Curve | 2 | 2009 | 445 | 0.090 |
Why?
| Retrospective Studies | 6 | 2022 | 12515 | 0.090 |
Why?
| HIV Infections | 1 | 2023 | 2469 | 0.080 |
Why?
| Fetal Weight | 1 | 2009 | 52 | 0.080 |
Why?
| Stress, Psychological | 1 | 2017 | 944 | 0.080 |
Why?
| Chikungunya Fever | 2 | 2021 | 61 | 0.080 |
Why?
| Mycobacterium tuberculosis | 1 | 2012 | 268 | 0.080 |
Why?
| Pregnancy in Diabetics | 1 | 2009 | 82 | 0.080 |
Why?
| Solanum tuberosum | 1 | 2008 | 7 | 0.080 |
Why?
| Feeding Behavior | 1 | 2013 | 574 | 0.070 |
Why?
| Edible Grain | 1 | 2008 | 43 | 0.070 |
Why?
| Diagnostic Errors | 1 | 2009 | 148 | 0.070 |
Why?
| Feasibility Studies | 1 | 2010 | 737 | 0.070 |
Why?
| Bias | 1 | 2009 | 180 | 0.070 |
Why?
| Longitudinal Studies | 4 | 2018 | 2386 | 0.070 |
Why?
| Mental Health | 2 | 2023 | 560 | 0.070 |
Why?
| Radiographic Image Enhancement | 1 | 2007 | 52 | 0.070 |
Why?
| Self Disclosure | 1 | 2007 | 59 | 0.070 |
Why?
| Gestational Age | 1 | 2009 | 759 | 0.070 |
Why?
| Vegetables | 1 | 2008 | 133 | 0.070 |
Why?
| Birth Weight | 1 | 2009 | 440 | 0.070 |
Why?
| Mammography | 1 | 2007 | 105 | 0.070 |
Why?
| Students | 2 | 2023 | 501 | 0.070 |
Why?
| Weight Gain | 1 | 2009 | 452 | 0.070 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2013 | 1892 | 0.070 |
Why?
| Statistics, Nonparametric | 1 | 2007 | 386 | 0.070 |
Why?
| Multivariate Analysis | 1 | 2009 | 1435 | 0.070 |
Why?
| Mental Recall | 1 | 2007 | 171 | 0.060 |
Why?
| Risk | 2 | 2021 | 815 | 0.060 |
Why?
| Genetic Predisposition to Disease | 2 | 2013 | 2099 | 0.060 |
Why?
| Neuropsychological Tests | 2 | 2020 | 926 | 0.060 |
Why?
| Prognosis | 1 | 2013 | 3334 | 0.060 |
Why?
| Dietary Fats | 1 | 2007 | 287 | 0.060 |
Why?
| Nutritional Status | 1 | 2007 | 286 | 0.060 |
Why?
| Aged, 80 and over | 3 | 2023 | 6350 | 0.060 |
Why?
| Hospitals | 2 | 2021 | 580 | 0.060 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 2009 | 452 | 0.060 |
Why?
| Tobacco Smoke Pollution | 1 | 2007 | 217 | 0.060 |
Why?
| Databases, Factual | 2 | 2019 | 1128 | 0.060 |
Why?
| Mosquito Vectors | 1 | 2023 | 21 | 0.060 |
Why?
| Middle Aged | 6 | 2021 | 26757 | 0.060 |
Why?
| Chickens | 1 | 2023 | 177 | 0.050 |
Why?
| Larva | 1 | 2004 | 194 | 0.050 |
Why?
| Pyridoxine | 1 | 2022 | 28 | 0.050 |
Why?
| Hospitalization | 2 | 2022 | 1752 | 0.050 |
Why?
| Vomiting | 1 | 2023 | 123 | 0.050 |
Why?
| Cough | 1 | 2023 | 107 | 0.050 |
Why?
| Vital Signs | 1 | 2022 | 36 | 0.050 |
Why?
| Observational Studies as Topic | 1 | 2022 | 90 | 0.050 |
Why?
| Phenotype | 2 | 2022 | 2812 | 0.050 |
Why?
| Mass Screening | 1 | 2009 | 1003 | 0.050 |
Why?
| Mammals | 1 | 2023 | 245 | 0.050 |
Why?
| Aldehyde Dehydrogenase | 1 | 2022 | 134 | 0.050 |
Why?
| Fermentation | 1 | 2021 | 21 | 0.050 |
Why?
| Food Contamination | 1 | 2021 | 43 | 0.050 |
Why?
| Leukocyte Count | 1 | 2022 | 292 | 0.050 |
Why?
| World Health Organization | 1 | 2022 | 103 | 0.050 |
Why?
| Methylene Blue | 1 | 2021 | 22 | 0.050 |
Why?
| Equipment Reuse | 1 | 2021 | 11 | 0.050 |
Why?
| Attitude | 1 | 2023 | 229 | 0.050 |
Why?
| Decontamination | 1 | 2021 | 23 | 0.050 |
Why?
| Colorado | 2 | 2021 | 4086 | 0.050 |
Why?
| Influenza A Virus, H3N2 Subtype | 1 | 2021 | 40 | 0.050 |
Why?
| Brazil | 1 | 2021 | 90 | 0.050 |
Why?
| Spike Glycoprotein, Coronavirus | 1 | 2022 | 92 | 0.050 |
Why?
| Telephone | 1 | 2021 | 152 | 0.050 |
Why?
| Lead | 1 | 2021 | 43 | 0.050 |
Why?
| India | 1 | 2021 | 134 | 0.050 |
Why?
| Immunization | 1 | 2023 | 401 | 0.040 |
Why?
| Immunoglobulin M | 1 | 2022 | 250 | 0.040 |
Why?
| Diet Surveys | 2 | 2013 | 78 | 0.040 |
Why?
| Longevity | 1 | 2021 | 137 | 0.040 |
Why?
| Cluster Analysis | 1 | 2022 | 460 | 0.040 |
Why?
| Absenteeism | 1 | 2020 | 40 | 0.040 |
Why?
| Translations | 1 | 2020 | 16 | 0.040 |
Why?
| Chikungunya virus | 1 | 2021 | 61 | 0.040 |
Why?
| Respiratory Tract Diseases | 1 | 2021 | 139 | 0.040 |
Why?
| Parity | 1 | 2019 | 100 | 0.040 |
Why?
| Triage | 1 | 2021 | 192 | 0.040 |
Why?
| Prenatal Care | 1 | 2022 | 255 | 0.040 |
Why?
| Blood Glucose | 1 | 2008 | 1821 | 0.040 |
Why?
| Child Language | 1 | 2019 | 22 | 0.040 |
Why?
| Translating | 1 | 2019 | 36 | 0.040 |
Why?
| Rural Health | 1 | 2019 | 67 | 0.040 |
Why?
| Parasites | 1 | 2019 | 37 | 0.040 |
Why?
| RNA, Viral | 1 | 2022 | 566 | 0.040 |
Why?
| Arboviruses | 1 | 2018 | 10 | 0.040 |
Why?
| Dengue Vaccines | 1 | 2018 | 9 | 0.040 |
Why?
| Culturally Competent Care | 1 | 2019 | 48 | 0.040 |
Why?
| Seasons | 1 | 2021 | 450 | 0.040 |
Why?
| Thinness | 1 | 2019 | 87 | 0.040 |
Why?
| Pregnancy in Adolescence | 1 | 2019 | 80 | 0.040 |
Why?
| Pregnancy Outcome | 1 | 2020 | 337 | 0.040 |
Why?
| Ambulatory Care | 1 | 2021 | 479 | 0.040 |
Why?
| Proteins | 1 | 2004 | 912 | 0.040 |
Why?
| Vulnerable Populations | 1 | 2019 | 133 | 0.040 |
Why?
| Rare Diseases | 1 | 2018 | 89 | 0.040 |
Why?
| Mothers | 1 | 2023 | 651 | 0.040 |
Why?
| Chi-Square Distribution | 1 | 2019 | 494 | 0.040 |
Why?
| Anti-Infective Agents | 1 | 2020 | 225 | 0.040 |
Why?
| Choice Behavior | 1 | 2019 | 154 | 0.040 |
Why?
| Altitude | 1 | 2021 | 433 | 0.040 |
Why?
| Child Health | 1 | 2019 | 126 | 0.040 |
Why?
| Predictive Value of Tests | 1 | 2022 | 1796 | 0.040 |
Why?
| Medical Records | 1 | 2018 | 153 | 0.040 |
Why?
| Critical Care | 1 | 2021 | 473 | 0.040 |
Why?
| Glucose | 1 | 2022 | 897 | 0.040 |
Why?
| Research Design | 1 | 2023 | 931 | 0.040 |
Why?
| Health Surveys | 1 | 2019 | 443 | 0.040 |
Why?
| Child Behavior | 1 | 2019 | 220 | 0.030 |
Why?
| Internal-External Control | 1 | 2017 | 66 | 0.030 |
Why?
| Logistic Models | 1 | 2021 | 1843 | 0.030 |
Why?
| Risk-Taking | 1 | 2019 | 333 | 0.030 |
Why?
| Life Change Events | 1 | 2017 | 135 | 0.030 |
Why?
| Breast Neoplasms | 1 | 2007 | 1868 | 0.030 |
Why?
| Cognition | 1 | 2022 | 989 | 0.030 |
Why?
| Cities | 1 | 2015 | 80 | 0.030 |
Why?
| Data Collection | 1 | 2018 | 622 | 0.030 |
Why?
| Protective Factors | 1 | 2015 | 87 | 0.030 |
Why?
| Public Health | 1 | 2018 | 434 | 0.030 |
Why?
| Pandemics | 1 | 2022 | 1319 | 0.030 |
Why?
| Time Factors | 2 | 2015 | 6124 | 0.030 |
Why?
| Bacteria | 1 | 2019 | 726 | 0.030 |
Why?
| Severity of Illness Index | 1 | 2020 | 2539 | 0.030 |
Why?
| Health Promotion | 1 | 2019 | 686 | 0.030 |
Why?
| Adaptation, Psychological | 1 | 2017 | 547 | 0.030 |
Why?
| Genetic Markers | 1 | 2013 | 321 | 0.030 |
Why?
| Risk Assessment | 1 | 2021 | 2973 | 0.030 |
Why?
| Comorbidity | 1 | 2017 | 1449 | 0.030 |
Why?
| Maryland | 1 | 2012 | 37 | 0.030 |
Why?
| Virginia | 1 | 2012 | 51 | 0.030 |
Why?
| Automobiles | 1 | 2012 | 19 | 0.020 |
Why?
| Survival Analysis | 1 | 2015 | 1218 | 0.020 |
Why?
| Tuberculin Test | 1 | 2012 | 32 | 0.020 |
Why?
| Genetic Association Studies | 1 | 2013 | 344 | 0.020 |
Why?
| Biomarkers | 2 | 2015 | 3416 | 0.020 |
Why?
| Aged | 2 | 2021 | 19094 | 0.020 |
Why?
| Environmental Exposure | 1 | 2012 | 374 | 0.020 |
Why?
| Clinical Laboratory Techniques | 1 | 2009 | 87 | 0.020 |
Why?
| Fatty Acids, Omega-6 | 1 | 2007 | 45 | 0.020 |
Why?
| Research Personnel | 1 | 2009 | 151 | 0.020 |
Why?
| Carotenoids | 1 | 2007 | 35 | 0.020 |
Why?
| Vitamins | 1 | 2007 | 151 | 0.020 |
Why?
| Infant Nutritional Physiological Phenomena | 1 | 2007 | 133 | 0.020 |
Why?
| Decision Support Techniques | 1 | 2009 | 351 | 0.020 |
Why?
| Early Detection of Cancer | 1 | 2009 | 328 | 0.020 |
Why?
| Models, Statistical | 1 | 2009 | 604 | 0.020 |
Why?
| Clinical Trials as Topic | 1 | 2007 | 935 | 0.010 |
Why?
|
|
Lamb's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|